A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

NCT02064010 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Funding terminated; company closed

Conditions

Drug-induced Tardive Dyskinesia

Interventions

DRUG: SNC-102
DRUG: Placebo

Sponsor

Synchroneuron Inc.